Effect of silymarin on DOCA salt streptozotocin induced diabetic hypertension in unilateral nephrectomized rats

International Journal of Pharmaceutical Research

Volumn 3, Issue 1, 2011, Pages 27-32

  Jadhav, G B ^a   Upasani, C D ^b  

^a R G Sapkal College of Pharmacy   (India)

^b UNIVERSITY OF PUNE   (India)

Author keywords

Antioxidant; Diabetes; DOCA; Hypertension; Silymarin; Streptozotocin

Indexed keywords

ADRENALIN; ANTIOXIDANT; CATALASE; DEOXYCORTICOSTERONE ACETATE; GLIBENCLAMIDE; GLUCOSE; GLUTATHIONE; LIPID; LISINOPRIL; NORADRENALIN; PHENYLEPHRINE; POTASSIUM; SEROTONIN; SILYMARIN; SODIUM; STREPTOZOCIN; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DIABETIC HYPERTENSION; DRUG EFFECT; FEMALE; FLAME PHOTOMETRY; GLUCOSE BLOOD LEVEL; HEART RATE; HISTOPATHOLOGY; LIPID BLOOD LEVEL; NONHUMAN; POTASSIUM URINE LEVEL; PRESSOR RESPONSE; RAT; SODIUM URINE LEVEL; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION;

EID: 79954511792     PISSN: None     EISSN: 09752366     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Miesel A, Müller H, Thermann M, Heidbreder M, Dominiak P. Overfeeding-Induced Obesity in Spontaneously Hypertensive Rats: An Animal Model of the Human Metabolic Syndrome. Ann Nutr Metab 2010; 56-59.
2. Sevak AR and Goyal RK. Effects of chronic treatment with lisinopril on cardiovascular complications in Streptozotocin diabetic and DOCA hypertensive rats. Phramacological Research 1996; 34 (5): 202-209.
3. Young LD, Yu D, Freeman D, Brock GB. Effect of PDE5 inhibition combined with free oxygen radical scavenger therapy on erectile function in a diabetic animal model. International Journal of Impotence Research 2003; 15:347-354.
4. Hofman C, Limor R, Rosenthal T, Zaid, Stern N.P- 479: Intrarenal and cardiac expression of endothelin-1, ETA and ETB receptors in Cohen-Rosenthal Diabetic Hypertensive rats. Am J Hypertens 2005; 18: 180A- 181A
5. AWE SO, Tsakadze NL, Stanley E et al. tert-Butyl hydroperoxide mediated vascular responces in DOCA Nsalt hypertensive rats. Vascular Pahrmacology 2003; 40: 51-57.
6. Weiss, R., Fintelmann, V.(2000) Herbal Medicine, 2nd ed. Thieme, Stuttgart,New York, pp. 109-111.
7. Dixit N, Baboota S, Kohli K, Ali J. Silymarin: A review of pharmacological aspects and bioavailability enhancement approaches, Indian Journal Pharmacology 2007; 39(4): 172-179.
8. Stephen M. Sagar B. et al. Future directions for research on Silybum marianum for cancer patients. Integr Cancer Therapy 2007; 6:166- 1673.
9. Trease EG. Evans WC. Textbook of pharmacognosy, 12 ed. Singapore: Alden Press.2005.
10. Nakagawa M., Nasjletti A. Plasma rennin concentration in Deoxycorticosterone salt hypertension. Hypertension 1998; 11: 411-415.
11. Rodrigues B, Goyal RK, McNeil JH. Effects of Hydralzine on STZ induced diabetic rats prevention of hyperlipidemia and improvement in cardiac function. J Pharmac Expt Ther 1986;237: 299-307.
12. Badyal DK, Lata H, Dadhich AP. Animal model of hypertension and effect of drugs. Indian J. Pharmacol 2003; 35: 349-362.
13. Seyle H., Bois P. The hormonal production of nephrosclerosis and periarteritis nodosa in the primate. Br Med J 1957; 1:183-186.
14. Vogel HG, Wolfgand (Eds). Drug Discovery and Evaluation-pharmacological assays. 2nd ed. Springer publication, Germany. 1997; pp 122-124.
15. Damanhori AH, Khaja AI, Seueria RP. Gender based treatment outcomes in diabetes hypertension. J post grand Med 2008; 54: 212-54.
16. Trinder P:Determination of blood glucose using an oxidase-peroxidase system with a noncarcinogenic chromogen, J Clin Pathol 1969; 22: 158- 162.
17. Katholi RE, Naftilan AJ, Oparil S. Importance of renal sympathetic tone in the development of DOCAsalt hypertension in the rat. Hypertension 2007; 2, 266-273.
18. Saggu H., Cooksey J, Dexter D. A selective increase in particulate Superoxide dismutase activity in Parkinsonin subtansia nigra. J Neurochem1989; 53, 692-697.
19. Misra HP, Fridovich I. The generation Superoxide radical during the autooxidation of hemoglobin. J Bio Chem 1972; 247, 6960-6962.
20. Luna LG: Manual of histopathological staining methods of the armed forces institute of pathology, 3rd ed. McGraw hill Book Co; New York; 1968.
21. Damanhori A. H., Khaja A. I., Seueria R. P: Gender based treatment outcomes in diabetes hypertension. J. post grand. Med., 2008; 54: 123-125.
22. Wang Yand Walsh SW. Aspirin inhibits both lipid peroxides and thromboxane in preeclamptic placentas. Free Radic Biol Med 1995; 18: 585-591.
23. Vaziri ND., Rodriguez-Lturbe B. Mechanisms of disease: Oxidative stress and inflammation in the pathogenesis of hypertension. Nat Cli Pract Nephrol 2006; 2:582-593.
24. Beswick RA, Dorrance AM, Leite R, Webb RC. NADH/NADPH oxidase and enhanced superoxide production in the mineralocorticoid hypertensive rat. Hypertension 2001; 38, 1107-1111.
25. Gazak R, Svobodova A, Pstova J, Sedmera P, et al. Oxidized derivatives of Silybin and their antiradical and antioxidant activity. Bioorgan Medical Che 2004; 12:5677-5687.